Variant report
| Variant | nsv971218 |
|---|---|
| Chromosome Location | chr7:103561948-103585213 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:21)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
(count:21 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr7:103557671..103561484-chr7:103568838..103571877,3 | K562 | blood: | |
| 2 | chr7:103580049..103581812-chr7:103595341..103598301,2 | K562 | blood: | |
| 3 | chr7:103532058..103533775-chr7:103563141..103565632,2 | K562 | blood: | |
| 4 | chr7:103574683..103576382-chr7:103587252..103589480,2 | K562 | blood: | |
| 5 | chr7:103558397..103560497-chr7:103570377..103574513,3 | K562 | blood: | |
| 6 | chr7:103562037..103563757-chr7:103575522..103577344,2 | K562 | blood: | |
| 7 | chr7:103567609..103572378-chr7:103572884..103577140,9 | K562 | blood: | |
| 8 | chr7:103545125..103546646-chr7:103570304..103572979,2 | K562 | blood: | |
| 9 | chr7:103560989..103563112-chr7:103570075..103571747,2 | K562 | blood: | |
| 10 | chr7:103562037..103563757-chr7:103575522..103577344,2 | K562 | blood: | |
| 11 | chr7:103581356..103582856-chr7:103585728..103588063,2 | K562 | blood: | |
| 12 | chr7:103567609..103572378-chr7:103572884..103577140,9 | K562 | blood: | |
| 13 | chr7:103558002..103560953-chr7:103574688..103576849,2 | K562 | blood: | |
| 14 | chr7:103575744..103578480-chr7:103589685..103593226,3 | K562 | blood: | |
| 15 | chr7:103553214..103555201-chr7:103575018..103577622,2 | K562 | blood: | |
| 16 | chr7:103564555..103566285-chr7:103650093..103652730,2 | K562 | blood: | |
| 17 | chr7:103560989..103563112-chr7:103570075..103571747,2 | K562 | blood: | |
| 18 | chr7:103576100..103578480-chr7:103589685..103592644,2 | K562 | blood: | |
| 19 | chr7:103559557..103561954-chr7:103587104..103589097,2 | K562 | blood: | |
| 20 | chr7:103510796..103513502-chr7:103565026..103567236,2 | K562 | blood: | |
| 21 | chr7:103561421..103564064-chr7:103629667..103633796,3 | K562 | blood: |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| ENSG00000189056 | chromatin interactions |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs372837627 | chr7:103561969-103561970 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 2 | rs570249433 | chr7:103561977-103561978 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 3 | rs138605131 | chr7:103561989-103561990 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 4 | rs116370516 | chr7:103562028-103562029 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 5 | rs55833200 | chr7:103562035-103562036 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 6 | rs756434 | chr7:103562036-103562037 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 7 | rs114079971 | chr7:103562089-103562090 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 8 | rs386716383 | chr7:103562111-103562112 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 9 | rs756435 | chr7:103562112-103562113 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 10 | rs368643908 | chr7:103562141-103562142 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 11 | rs117893897 | chr7:103562155-103562156 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 12 | rs559073048 | chr7:103562234-103562235 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 13 | rs141599561 | chr7:103562241-103562242 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 14 | rs146208912 | chr7:103562245-103562246 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 15 | rs58751603 | chr7:103562258-103562259 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 16 | rs574596482 | chr7:103562275-103562276 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 17 | rs112573534 | chr7:103562290-103562291 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 18 | rs58062233 | chr7:103562292-103562293 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 19 | rs139120729 | chr7:103562341-103562342 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 20 | rs190342438 | chr7:103562350-103562351 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 21 | rs78728005 | chr7:103562440-103562441 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 22 | rs756436 | chr7:103562444-103562445 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 23 | rs546662482 | chr7:103562469-103562470 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 24 | rs528209216 | chr7:103562474-103562475 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 25 | rs10277802 | chr7:103562551-103562552 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 26 | rs547917063 | chr7:103562617-103562618 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 27 | rs532399373 | chr7:103562647-103562648 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 28 | rs568051559 | chr7:103562716-103562717 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 29 | rs368277303 | chr7:103562752-103562753 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 30 | rs10277860 | chr7:103562762-103562763 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 31 | rs113228864 | chr7:103562790-103562791 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 32 | rs548854948 | chr7:103562798-103562799 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 33 | rs371169809 | chr7:103562818-103562819 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 34 | rs537613190 | chr7:103562830-103562831 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 35 | rs144183608 | chr7:103562886-103562887 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 36 | rs533396161 | chr7:103562898-103562899 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 37 | rs111409328 | chr7:103562927-103562928 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 38 | rs550913094 | chr7:103563009-103563010 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 39 | rs550212227 | chr7:103563073-103563074 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 40 | rs148679570 | chr7:103563077-103563078 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 41 | rs553235932 | chr7:103563112-103563113 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 42 | rs574765492 | chr7:103563124-103563125 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 43 | rs7792066 | chr7:103563145-103563146 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 44 | rs563222974 | chr7:103563146-103563147 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 45 | rs182111232 | chr7:103563173-103563174 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 46 | rs575186778 | chr7:103563206-103563207 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 47 | rs142168776 | chr7:103563216-103563217 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 48 | rs73712299 | chr7:103563222-103563223 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 49 | rs528127363 | chr7:103563228-103563229 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| 50 | rs185998698 | chr7:103563260-103563261 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17170743 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Seminomas | 18059402 | CNVD |
| Testicular cancer | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Autism | 19415332 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Malaria | 21533027 | CNVD |
| Melanoma | 18172304 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| head and neck squamous cell carcinoma | 19289630 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| Autism | 22495311 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Gastric cancer | 24379144 | CNVD |
| Glioblastoma multiforme | 17002787 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Lissencephaly | 21572526 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Squamous cell cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Low-grade fibromyxoid sarcoma | 0 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Shwachman-Diamond syndrome | 22934832 | CNVD |
| Colorectal cancer | 19359472 | CNVD |
| Cutaneous malignant melanoma | 17690212 | CNVD |
| Leukemia | 17361228 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Peripheral t-cell lymphoma | 19118030 | CNVD |
| Malignant melanoma | 17690212 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Neurodevelopmental disorder | 22521361 | CNVD |
| abortions and stillbirths | 19751515 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Prostate cancer | 16461572 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Burkitt''s lymphoma | 19759907 | CNVD |
| Malignant melanoma | 17260012 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Bladder cancer | 21909424 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Splenic marginal zone lymphoma | 21957467 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Primary central nervous system lymphoma | 21088137 | CNVD |
| Liver carcinoma | 19366792 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Adenocarcinoma | 19607727 | CNVD |
| Multiple myeloma | 16461302 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Emphysema | 19352772 | CNVD |
| Effusion lymphoma | 18079361 | CNVD |
| Medulloblastoma | 17653508 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Autism | 19401682 | CNVD |
| Neuroticism | 17667963 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Cancer | 19907438 | CNVD |
| Breast cancer | 21364760 | CNVD |
| abnormal development | 18461090 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Prostate cancer | 21147910 | CNVD |
| Cancer | 20164919 | CNVD |
| Breast cancer | 22522925 | CNVD |
| Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
| Pancreatic cancer | 17952125 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr7:103556800-103574400 | Weak transcription | HepG2 | liver |
| 2 | chr7:103561600-103564400 | Enhancers | K562 | blood |
| 3 | chr7:103562000-103562400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
| 4 | chr7:103564400-103564800 | Weak transcription | K562 | blood |
| 5 | chr7:103564800-103565000 | Enhancers | K562 | blood |
| 6 | chr7:103565000-103571600 | Weak transcription | K562 | blood |
| 7 | chr7:103570200-103570800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 8 | chr7:103570600-103571800 | Enhancers | Fetal Brain Male | brain |
| 9 | chr7:103571600-103572200 | Strong transcription | K562 | blood |
| 10 | chr7:103572200-103574000 | Weak transcription | K562 | blood |
| 11 | chr7:103574000-103574600 | Enhancers | K562 | blood |
| 12 | chr7:103574400-103575400 | Strong transcription | HepG2 | liver |
| 13 | chr7:103574600-103590200 | Weak transcription | K562 | blood |
| 14 | chr7:103574800-103575400 | Enhancers | Brain Anterior Caudate | brain |
| 15 | chr7:103575400-103582800 | Weak transcription | HepG2 | liver |
| 16 | chr7:103576800-103577400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 17 | chr7:103577400-103580800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 18 | chr7:103580600-103581800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
| 19 | chr7:103580800-103581800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 20 | chr7:103582800-103583200 | Enhancers | HepG2 | liver |
| 21 | chr7:103583200-103584800 | Weak transcription | HepG2 | liver |
| 22 | chr7:103584400-103584600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
| 23 | chr7:103584800-103585400 | Strong transcription | HepG2 | liver |
| 24 | chr7:103584800-103596800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |






